165 related articles for article (PubMed ID: 34215321)
1. Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis.
Cao M; Liu H; Dong Y; Liu W; Yu Z; Wang Q; Wang Q; Liang Z; Li Y; Ren H
Stem Cell Res Ther; 2021 Jul; 12(1):378. PubMed ID: 34215321
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cells Enhance Chemotaxis of Activated T Cells through the CCL2-CCR2 Axis In Vitro.
Zhang YL; Qiao SK; Xing LN; Guo XN; Ren JH
Bull Exp Biol Med; 2021 Dec; 172(2):263-269. PubMed ID: 34855085
[TBL] [Abstract][Full Text] [Related]
3. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.
Cui R; Rekasi H; Hepner-Schefczyk M; Fessmann K; Petri RM; Bruderek K; Brandau S; Jäger M; Flohé SB
Stem Cell Res Ther; 2016 Jul; 7(1):88. PubMed ID: 27388156
[TBL] [Abstract][Full Text] [Related]
4. A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.
Hildebrandt GC; Duffner UA; Olkiewicz KM; Corrion LA; Willmarth NE; Williams DL; Clouthier SG; Hogaboam CM; Reddy PR; Moore BB; Kuziel WA; Liu C; Yanik G; Cooke KR
Blood; 2004 Mar; 103(6):2417-26. PubMed ID: 14615370
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic Compact Bone-Derived Mesenchymal Stem Cell Transplantation Attenuates the Severity of Idiopathic Pneumonia Syndrome in a Murine Bone Marrow Transplantation Model.
Qiao SK; Ren HY; Shi YJ; Liu W
Cell Physiol Biochem; 2016; 40(6):1656-1669. PubMed ID: 28006781
[TBL] [Abstract][Full Text] [Related]
6. Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells.
Panoskaltsis-Mortari A; Hermanson JR; Taras E; Wangensteen OD; Charo IF; Rollins BJ; Blazar BR
Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L284-92. PubMed ID: 14527928
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the Therapeutic Potential of
Lee S; Kim OJ; Lee KO; Jung H; Oh SH; Kim NK
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096826
[TBL] [Abstract][Full Text] [Related]
8. Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.
Yamazaki S; Mabuchi Y; Kimura T; Suto EG; Hisamatsu D; Naraoka Y; Kondo A; Azuma Y; Kikuchi R; Nishikii H; Morishita S; Araki M; Komatsu N; Akazawa C
Stem Cell Reports; 2024 Mar; 19(3):414-425. PubMed ID: 38428413
[TBL] [Abstract][Full Text] [Related]
9. The effect of mesenchymal stem cells on chemotaxis of osteoclast precursor cells.
Sumi K; Abe T; Kunimatsu R; Oki N; Tsuka Y; Awada T; Nakajima K; Ando K; Tanimoto K
J Oral Sci; 2018; 60(2):221-225. PubMed ID: 29925706
[TBL] [Abstract][Full Text] [Related]
10. CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury.
Jablonski CL; Leonard C; Salo P; Krawetz RJ
J Orthop Res; 2019 Dec; 37(12):2561-2574. PubMed ID: 31424112
[TBL] [Abstract][Full Text] [Related]
11. CCR2-overexpressing mesenchymal stem cells targeting damaged liver enhance recovery of acute liver failure.
Xu R; Ni B; Wang L; Shan J; Pan L; He Y; Lv G; Lin H; Chen W; Zhang Q
Stem Cell Res Ther; 2022 Feb; 13(1):55. PubMed ID: 35123561
[TBL] [Abstract][Full Text] [Related]
12. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
13. Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.
Martinu T; Gowdy KM; Nugent JL; Sun J; Kinnier CV; Nelson ME; Lyes MA; Kelly FL; Foster WM; Gunn MD; Palmer SM
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):810-21. PubMed ID: 24921973
[TBL] [Abstract][Full Text] [Related]
14. Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.
Ben-Yehuda H; Arad M; Peralta Ramos JM; Sharon E; Castellani G; Ferrera S; Cahalon L; Colaiuta SP; Salame TM; Schwartz M
Mol Neurodegener; 2021 Jun; 16(1):39. PubMed ID: 34172073
[TBL] [Abstract][Full Text] [Related]
15. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
16. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers.
Huang B; Lei Z; Zhao J; Gong W; Liu J; Chen Z; Liu Y; Li D; Yuan Y; Zhang GM; Feng ZH
Cancer Lett; 2007 Jul; 252(1):86-92. PubMed ID: 17257744
[TBL] [Abstract][Full Text] [Related]
17. CCL2/CCR2-dependent recruitment of Th17 cells but not Tc17 cells to the lung in a murine asthma model.
Wang A; Wang Z; Cao Y; Cheng S; Chen H; Bunjhoo H; Xie J; Wang C; Xu Y; Xiong W
Int Arch Allergy Immunol; 2015; 166(1):52-62. PubMed ID: 25765592
[TBL] [Abstract][Full Text] [Related]
18. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
[TBL] [Abstract][Full Text] [Related]
19. Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor.
Asai H; Fujiwara H; An J; Ochi T; Miyazaki Y; Nagai K; Okamoto S; Mineno J; Kuzushima K; Shiku H; Inoue H; Yasukawa M
PLoS One; 2013; 8(2):e56820. PubMed ID: 23441216
[TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
